Titan Biotech Limited (BOM:524717)
India
· Delayed Price · Currency is INR 452.60
-15.80 (-3.37%)
At close: Apr 28, 2026
Titan Biotech Revenue
Titan Biotech had revenue of 565.06M INR in the quarter ending December 31, 2025, with 47.63% growth. This brings the company's revenue in the last twelve months to 1.93B, up 19.43% year-over-year. In the fiscal year ending March 31, 2025, Titan Biotech had annual revenue of 1.56B, down -4.65%.
Revenue (ttm)
1.93B
Revenue Growth
+19.43%
P/S Ratio
9.71
Revenue / Employee
4.12M
Employees
467
Market Cap
18.70B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.56B | -76.21M | -4.65% |
| Mar 31, 2024 | 1.64B | 200.73M | 13.94% |
| Mar 31, 2023 | 1.44B | 204.50M | 16.55% |
| Mar 31, 2022 | 1.24B | -186.92M | -13.14% |
| Mar 31, 2021 | 1.42B | 628.00M | 79.05% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dynamic Cables | 11.74B |
| G N A Axles | 14.21B |
| Somany Ceramics | 27.41B |
| Elpro International | 4.93B |
| TCC Concept | 1.28B |
| Apollo Pipes | 10.73B |
| Geojit Financial Services | 6.45B |
| Mold-Tek Packaging | 8.51B |